Researchers also saw fewer COPD flare-ups, though they say trials built around breathing outcomes are the next step before drawing firm conclusions.
Recap by typeshit. Full story at Hospital Pharmacy Europe.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Fox News reports that semaglutide and tirzepatide may ease joint pain, inflammation and organ strain early in treatment, before much weight comes off.
The seven-step, needle-free facial costs $299 a visit or $239 a month at Silver Mirror's 10 studios. The company says it is not a medical procedure.
Loading…